Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Racial minorities face higher costs for unplanned hospital visits after breast reconstruction.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

PPX causes much less hair loss than traditional taxanes.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Alopecia areata and myasthenia gravis can occur as rare symptoms of breast cancer.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

A new method accurately measures cell changes in breast cancer.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Spiritual well-being improves quality of life for Palestinian women with breast cancer.

Alopecia from CDK 4/6 inhibitors worsens quality of life in breast cancer patients.

Stopping Viviscal, a hair loss product, normalized the woman's elevated alkaline phosphatase levels.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Scalp cryotherapy significantly reduces hair loss during and shortly after chemotherapy.